Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.

Andishe AttarbaschiGeorg MannMartin ZimmermannPeter BaderElena BarisoneGiuseppe BassoAndrea BiondiGunnar CarioGiovanni CazzanigaAntonella ColombiniChristian FlothoMichaela KuhlenPeter LangMelchior LautenChristin LinderkampFranco LocatelliLuca Lo NigroAnja MörickeFelix NiggliRenate Panzer-GrümayerRosanna ParasoleChristina PetersMaria Caterina PuttiCarmelo RizzariMeinolf SuttorpMaria Grazia ValsecchiValentino ConterMartin Schrappenull null

Published in: Leukemia (2019)

Keyphrases

acute lymphoblastic leukemia
phase iii
phase ii
open label
double blind
clinical trial
placebo controlled
study protocol
allogeneic hematopoietic stem cell transplantation
stem cells
bone marrow
cell therapy
young adults
replacement therapy